Carole Creuzenet

Dr. Carole Creuzenet

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PHPatrick S. Hopf
Patrick S. Hopf
RFRachel S. Ford
Rachel S. Ford
NZNajwa Zebian
Najwa Zebian
AMAlexandra Merkx-Jacques
Alexandra Merkx-Jacques
SVSomalinga Vijayakumar
Somalinga Vijayakumar
CCCarole Creuzenet
Carole Creuzenet
Glycosylation of flagellins by pseudaminic acid is required for virulence in Helicobacter pylori. We demonstrate that, in H. pylori, glycosylation extends to proteins other than flagellins and to sugars other than pseudaminic acid. Several candidate glycoproteins distinct from the flagellins were detected via ProQ-emerald staining and DIG- or biotin- hydrazide labeling of the soluble and outer membrane fractions of wild-type H. pylori, suggesting that protein glycosylation is not limited to the flagellins. DIG-hydrazide labeling of proteins from pseudaminic acid biosynthesis pathway mutants showed that the glycosylation of some glycoproteins is not dependent on the pseudaminic acid glycosylation pathway, indicating the existence of a novel glycosylation pathway. Fractions enriched in glycoprotein candidates by ion exchange chromatography were used to extract the sugars by acid hydrolysis. High performance anion exchange chromatography with pulsed amperometric detection revealed characteristic monosaccharide peaks in these extracts. The monosaccharides were then identified by LC-ESI-MS/MS. The spectra are consistent with sugars such as 5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-L-manno-nonulosonic acid (Pse5Ac7Ac) previously described on flagellins, 5-acetamidino-7-acetamido-3,5,7,9-tetradeoxy-L-glycero-L-manno-nonulosonic acid (Pse5Am7Ac), bacillosamine derivatives and a potential legionaminic acid derivative (Leg5AmNMe7Ac) which were not previously identified in H. pylori. These data open the way to the study of the mechanism and role of protein glycosylation on protein function and virulence in H. pylori.

17 November 2015 in Glycobiology
Verified
Journal Article
Closed access
PDF file
NZNajwa Zebian
Najwa Zebian
AMAlexandra Merkx-Jacques
Alexandra Merkx-Jacques
PPPaula P Pittock
Paula P Pittock
SHSebastien Houle
Sebastien Houle
CDCharles M Dozois
Charles M Dozois
CCCarole Creuzenet
Carole Creuzenet
Campylobacter jejuni is the leading cause of bacterial gastroenteritis. It relies on several virulence factors for host colonization, including glycosylated flagella. C. jejuni NCTC 11168 modifies its flagellins with pseudaminic acid derivatives. It is also presumed to modify these proteins with legionaminic acid, although no glycopeptide evidence was available at the onset of this study. The enzyme encoded by cj1319 can be used to make legionaminic acid in vitro, but the pathway for legionaminic acid synthesis partially inferred by knockout mutagenesis in Campylobacter coli VC167 excludes Cj1319. To address this contradiction, we examined the presence of legionaminic acid in flagellin glycopeptides of wild-type (WT) C. jejuni NCTC 11168 and of a cj1319 knockout mutant. We used high-energy collision-induced dissociation to obtain amino acid sequences while also visualizing signature sugar oxonium ions. Data analysis was performed with PEAKS software, and spectra were manually inspected for glycopeptide determination and verification. We showed that legionaminic acid is present on the flagellins of C. jejuni NCTC 11168 and that flagellin glycosylation is highly heterogeneous, with up to six different sugars singly present at a given site. We found that the cj1319 mutant produces more legionaminic acid than WT, thus excluding the requirement for Cj1319 for legionaminic acid synthesis. We also showed that this mutant has enhanced chicken colonization compared with WT, which may in part be attributed to the high content of legionaminic acid on its flagella.

1 September 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YMYasmine Fathy Mohamed
Yasmine Fathy Mohamed
NSNichollas E. Scott
Nichollas E. Scott
AMAntonio Molinaro
Antonio Molinaro
CCCarole Creuzenet
Carole Creuzenet
XOXimena Ortega
Ximena Ortega
Miguel ValvanoMiguel Valvano
Miguel Valvano
The Burkholderia genus encompasses many Gram-negative bacteria living in the rhizosphere. Some Burkholderia species can cause life-threatening human infections, highlighting the need for clinical interventions targeting specific lipopolysaccharide proteins. Burkholderia cenocepacia O-linked protein glycosylation has been reported, but the chemical structure of the O-glycan and the machinery required for its biosynthesis are unknown and could reveal potential therapeutic targets. Here, using bioinformatics approaches, gene-knockout mutants, purified recombinant proteins, LC-MS–based analyses of O-glycans, and NMR-based structural analyses, we identified a B. cenocepacia O-glycosylation (ogc) gene cluster necessary for synthesis, assembly, and membrane translocation of a lipid-linked O-glycan, as well as its structure, which consists of a β-Gal-(1,3)–α-GalNAc-(1,3)–β-GalNAc trisaccharide. We demonstrate that the ogc cluster is conserved in the Burkholderia genus, and we confirm the production of glycoproteins with similar glycans in the Burkholderia species: B. thailandensis, B. gladioli, and B. pseudomallei. Furthermore, we show that absence of protein O-glycosylation severely affects bacterial fitness and accelerates bacterial clearance in a Galleria mellonella larva infection model. Finally, our experiments revealed that patients infected with B. cenocepacia, Burkholderia multivorans, B. pseudomallei, or Burkholderia mallei develop O-glycan–specific antibodies. Together, these results highlight the importance of general protein O-glycosylation in the biology of the Burkholderia genus and its potential as a target for inhibition or immunotherapy approaches to control Burkholderia infections.

11 April 2015 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
AWAnthony Wong
Anthony Wong
DLDirk Lange
Dirk Lange
SHSebastien Houle
Sebastien Houle
NANikolay P. Arbatsky
Nikolay P. Arbatsky
Miguel ValvanoMiguel Valvano
Miguel Valvano
CCCarole Creuzenet
Carole Creuzenet


15 April 2004 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
AMA. Merkx-Jacques
A. Merkx-Jacques
ROR. K. Obhi
R. K. Obhi
GBG. Bethune
G. Bethune
CCCarole Creuzenet
Carole Creuzenet
flaA1andwbpBare conserved genes with unknown biological function inHelicobacter pylori.Since both genes are predicted to be involved in lipopolysaccharide (LPS) biosynthesis, flagellum assembly, or protein glycosylation, they could play an important role in the pathogenesis ofH. pylori.To determine their biological role, both genes were disrupted in strain NCTC 11637. Both mutants exhibited altered LPS, with loss of most O-antigen and core modification, and increased sensitivity to sodium dodecyl sulfate compared to wild-type bacteria. These defects could be complemented in a gene-specific manner. Also,flaA1could complement these defects in thewbpBmutant, suggesting a potential redundancy of the reductase activity encoded by both genes. Both mutants were nonmotile, although thewbpBmutant still produced flagella. The defect in the flagellum functionality of this mutant was not due to a defect in flagellin glycosylation since flagellins from wild-type strain NCTC 11637 were shown not to be glycosylated. TheflaA1mutant produced flagellins but no flagellum. Overall, the similar phenotypes observed for both mutants and the complementation of thewbpBmutant byflaA1suggest that both genes belong to the same biosynthesis pathway. The data also suggest thatflaA1andwbpBare at the interface between several pathways that govern the expression of different virulence factors. We propose that FlaA1 and WbpB synthesize sugar derivatives dedicated to the glycosylation of proteins which are involved in LPS and flagellum production and that glycosylation regulates the activity of these proteins.